To further evaluate the therapeutic efficacy of NPs containing both CsA and Gef, we established an NSCLC xenograft-bearing BALB/c nude mouse model by implanting EGFR-TKI-resistant PC-9-GR cells into immunodeficient mice. This evidence concerns the gene EGFR and non-small cell lung carcinoma.